Autores: Adrián Pérez-Aranda (1, 2, 3, 4);Laura Andrés-Rodríguez (1, 2, 3);Albert Feliu-Soler (1, 2, 3);Christian Núñez (2, 5);Christian Stephan-Otto (2, 5, 6);María Ángeles Pastor-Mira (7);Sofía López-Roig (7);Cecilia Peñacoba (8);Elena Pita Calandre (9);Mahmoud Slim (10);Monika Salgueiro (11);Guillem Feixas (4, 12);Juan Vicente Luciano (1, 2, 3)
Centros Participantes: (1) Group of Psychological Research in Fibromyalgia and Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain, (2) Teaching, Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain, (3) Primary Care Prevention and Health Promotion Research Network, RedIAPP, Madrid, Spain, (4) Department of Clinical Psychology and Psychobiology (Section Personality, Assessment and Psychological Treatments), University of Barcelona, Barcelona, Spain, (5) Cerebral Imprints of Gender, Development and Pathology, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain, (6) Center for Biomedical Research in Mental Health, CIBERSAM, Madrid, Spain, (7) Department of Health Psychology, Miguel Hernández University, Elche, Spain, (8) Department of Medicine and Surgery, Public Health, Psychology and Immunology and Medical Microbiology, Rey Juan Carlos University, Madrid, Spain, (9) Instituto de Neurociencias Federico Olóriz, Universidad de Granada, Armilla, Spain, (10) Division of Neurology, The Hospital for Sick Children, Toronto, Canada, (11) Department of Psychiatry, Cruces University Hospital, Osakidetza-Basque Health System, BioCruces Health Research Institute, Barakaldo, Spain, (12) The Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
Referencia: 10.1097/j.pain.0000000000001468
Resumen: El objetivo principal de este estudio es identificar grupos de síndrome de fibromialgia (SMF) utilizando el Cuestionario de Impacto de Fibromialgia Revisado (FIQR), y examinar si los grupos difieren en características sociodemográficas, medidas clínicas, costes directos e indirectos, niveles de marcadores inflamatorios y morfometría cerebral. Se realizó un análisis jerárquico de grupos para clasificar una gran muestra agrupada de pacientes españoles con FMS (N = 947) utilizando el FIQR como variable de agrupamiento.